Analyst	Recommendation	Action	Price target	Projected	Date
Ashwani Verma UBS	Buy	Initiated	$52.00	+43.9%	09/01/2026
Salim Syed Mizuho Securities	Buy	Maintained	$53.00	+46.7%	08/31/2026
Patrick Trucchio H.C. Wainwright	Buy	Reiterated	$50.00	+38.4%	08/18/2026
Vamil Divan Guggenheim	Buy	Reiterated	$43.00	+19%	08/16/2026
Unknown Analyst Mizuho Securities	Buy	Maintained	$45.00	+24.6%	06/12/2026

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	10.79M	42.47M	8.21M	13.37M
Cost of goods sold	16.59M	17.25M	14.90M	14.92M
Cost of revenue	16.59M	17.25M	14.90M	14.92M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	5.08M	5.42M	4.68M	4.80M
Operating expense	5.08M	5.42M	4.68M	4.80M
Total operating expenses	21.67M	22.67M	19.58M	19.72M
Operating income	-10.88M	19.80M	-11.37M	-6.34M
Other non operating income	-	-	-	-
EBT including unusual items	-9.20M	22.09M	-9.08M	-3.86M
EBT excluding unusual items	-9.20M	22.09M	-9.08M	-3.86M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-9.20M	22.09M	-9.08M	-3.86M
Net profit margin	-85.23%	52.01%	-110.54%	-28.84%
Earnings per share	-0.72	2.48	-0.54	-0.20
Interest and investment income	1.69M	2.29M	2.29M	2.49M
Interest expense	-	-	-	-
Net interest expenses	1.69M	2.29M	2.29M	2.49M
Depreciation and amortization charges	-	-	-	-
EBITDA	-10.85M	19.83M	-11.34M	-6.32M
Gain or loss from assets sale	-	-	-	-

Ask anything